My Courses

In the first half of 2025, the Middle East’s M&A deal volumes grew by 19% — a significant growth relative to global M&A — according to analysis by professional services provider PwC….By: Skadden, Arps, Slate, Meagher & Flom LLP

As the global data center and related power infrastructure build-out continues at an unprecedented pace, the magnitude of the required capital is measured not in millions or billions but in trillions of dollars. J.P. Morgan recently estimated that at least $5 trillion will be required to fund the scale of the data center, artificial intelligence…

Businesses increasingly turn to algorithms to inform their pricing strategies, and courts, antitrust enforcers and legislatures are moving rapidly to grapple with legal and policy implications….By: Skadden, Arps, Slate, Meagher & Flom LLP

In the context of third-party liability claims, a familiar arrangement arises when an insurer retains defense counsel for its insured: the tripartite relationship among the insured, the insurer, and defense counsel. While common in automobile, general liability, and malpractice litigation, this arrangement raises recurring questions about the attorney-client privilege. Who holds the privilege? What is…

Glucagon-like peptide-1 receptor agonist drugs (commonly referred to as GLP-1 agonists) have become widely prescribed for type 2 diabetes and weight loss. Medications such as Ozempic, Wegovy, Mounjaro, and other GLP-1 drugs have been promoted for their effectiveness in controlling blood sugar and supporting weight reduction….By: Hissey, Mulderig & Friend, PLLC

AI chatbots are no longer a novelty. They are now embedded in social media platforms, search engines, and educational tools. Providers of AI chatbots face mounting scrutiny nationwide, as advocacy groups and legislators question the effects of chatbots on mental health, particularly for children….By: Kelley Drye & Warren LLP